therapeutic autologous lymphocytes [clinicaltrials_resource:a2530aa8d81f645a26f5be0ce7cfb7b5]
Lymphocyte Therapy in Treating Patients With Kidney Cancer [clinicaltrials:NCT00002589]clinicaltrials:NCT00003567Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00004022]Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [clinicaltrials:NCT00004024]Gene Therapy in Treating Patients With Cancer [clinicaltrials:NCT00004178]Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma [clinicaltrials:NCT00006480]Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00012207]Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer [clinicaltrials:NCT00014573]Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00019084]Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy [clinicaltrials:NCT00019357]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer [clinicaltrials:NCT00022230]Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer [clinicaltrials:NCT00030342]Biological Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00039299]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00045357]Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00046852]Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00079144]Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00085462]Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091104]Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00101257]Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma [clinicaltrials:NCT00101309]Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant [clinicaltrials:NCT00107354]Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma [clinicaltrials:NCT00138229]Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma [clinicaltrials:NCT00182650]Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00317759]Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme [clinicaltrials:NCT00331526]clinicaltrials:NCT00566098Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases [clinicaltrials:NCT00588913]
intervention [clinicaltrials_vocabulary:intervention]
therapeutic autologous lymphocytes [clinicaltrials_resource:a2530aa8d81f645a26f5be0ce7cfb7b5]
Bio2RDF identifier
a2530aa8d81f645a26f5be0ce7cfb7b5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a2530aa8d81f645a26f5be0ce7cfb7b5
intervention name [clinicaltrials_vocabulary:intervention-name]
therapeutic autologous lymphocytes
identifier
clinicaltrials_resource:a2530aa8d81f645a26f5be0ce7cfb7b5
title
therapeutic autologous lymphocytes
@en
type
label
therapeutic autologous lymphoc ...... 30aa8d81f645a26f5be0ce7cfb7b5]
@en